19 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
and ongoing regulatory requirements for manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion
6-K
EX-99.3
OBSVF
ObsEva SA
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging
6-K/A
EX-99.2
msaet7o3iv
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
7etax8qrspsgrzezpokl
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-1.1
mblp0t1wwlocm4k
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
lyh7uj81410tplywwai
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.1
e47fln6hu
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-1.1
8xvyb7o kzhw5c
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
20-F
l5cnq
21 Apr 17
Annual report (foreign)
12:00am
F-1
2eb4 rdeewpnoymyvoc
30 Dec 16
Registration statement (foreign)
12:00am
DRS
z1jkoa5wz8 qjbjtgysi
14 Oct 16
Draft registration statement
12:00am
- Prev
- 1
- Next